Literature DB >> 2438686

5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors.

P K Srivastava, Y T Chen, L J Old.   

Abstract

We have proposed that the distinct tumor rejection antigens of chemically induced sarcomas in inbred mice belong to a family of Mr 96,000 glycoproteins (gp96). An identical 14-amino acid sequence was found at the amino terminus of gp96 from two antigenically distinct BALB/c sarcomas. Oligonucleotide probes derived from this sequence permitted isolation of 5' cDNA and genomic fragments coding for gp96. Three short exons interrupted by relatively long introns were identified at the 5' terminus of the gp96 gene. The first exon encodes a signal peptide, which is consistent with gp96 being a cell surface antigen. Southern blot analysis indicated that the gp96 family is encoded by a single gene, and 3-kilobase transcripts were detected in all normal and tumor cells tested. Nucleotide and deduced amino acid sequences from 311 base paris at the 5' terminus showed no homology with any known protein. The availability of molecular probes for the gp96 system permits analysis of the structural polymorphism of these antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438686      PMCID: PMC304965          DOI: 10.1073/pnas.84.11.3807

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

Review 2.  Down-regulation of the antitumor immune response.

Authors:  R J North
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

Review 3.  Passive immunotherapy of cancer in animals and man.

Authors:  S A Rosenberg; W D Terry
Journal:  Adv Cancer Res       Date:  1977       Impact factor: 6.242

4.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

Review 5.  Can fetal antigens be used for prophylactic immunization?

Authors:  P B Medawar; R Hunt
Journal:  Ciba Found Symp       Date:  1983

6.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Surveillance, latency and the two levels of MCA-induced tumor immunogenicity.

Authors:  R T Prehn; G L Bartlett
Journal:  Int J Cancer       Date:  1987-01-15       Impact factor: 7.396

8.  Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma.

Authors:  D D Pravtcheva; A B DeLeo; F H Ruddle; L J Old
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C56Bl mice.

Authors:  S Johnson
Journal:  Br J Cancer       Date:  1968-03       Impact factor: 7.640

View more
  20 in total

Review 1.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94.

Authors:  T J Nieland; M C Tan; M Monne-van Muijen; F Koning; A M Kruisbeek; G M van Bleek
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 3.  Vaccine strategies for glioblastoma: progress and future directions.

Authors:  Christopher Jackson; Jacob Ruzevick; Henry Brem; Michael Lim
Journal:  Immunotherapy       Date:  2013-02       Impact factor: 4.196

4.  Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96.

Authors:  P K Srivastava; C A Kozak; L J Old
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

5.  Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's disease.

Authors:  K Schreiter; M Hausmann; T Spoettl; U G Strauch; F Bataille; J Schoelmerich; H Herfarth; W Falk; G Rogler
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

6.  Purification and characterization of an adenotin-like adenosine binding protein from human platelets.

Authors:  T Fein; E Schulze; J Bär; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

7.  Endo-beta-D-glucuronidase (heparanase) activity of heat-shock protein/tumour rejection antigen gp96.

Authors:  P K Srivastava
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

8.  A pathogen-induced gene of barley encodes a HSP90 homologue showing striking similarity to vertebrate forms resident in the endoplasmic reticulum.

Authors:  H Walther-Larsen; J Brandt; D B Collinge; H Thordal-Christensen
Journal:  Plant Mol Biol       Date:  1993-03       Impact factor: 4.076

Review 9.  Heat shock proteins transfer peptides during antigen processing and CTL priming.

Authors:  P K Srivastava; H Udono; N E Blachere; Z Li
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

10.  Tumour rejection antigens of the hsp90 family (gp96) closely resemble tumour-associated heparanase enzymes.

Authors:  L D Graham
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.